Hospira to acquire manufacturing facility from Orchid ChemicalsIllustrative image – not actual.

Hospira Inc, injectable generic drugs maker may acquire a factory and a research center from India based Orchid Chemicals & Pharmaceuticals.

The company is likely to be valued at $200 million (approx Rs 1,140 crore). Orchid’s factory, located in Aurangabad in Maharashtra, manufactures active pharmaceutical ingredients. The company has R&D facility in Chennai. With this acquisition, Hospira intends to reduce costs, help supply key antibiotic products and pave the way for development of active pharmaceutical ingredients.

← All latest storiesBack to top →